WHO ICTRP trial
Study to evaluate 2 types of treatment as first line treatment (masitinib +…
EUCTR2013-000809-23-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2013-000809-23-ES |
|---|---|
| Public title | Study to evaluate 2 types of treatment as first line treatment (masitinib + docetaxel or placebo + docetaxel ) in the treatment of patients with metastatic Castrate Resistant Prostate Cancer (mCRPC) |
| Scientific title | A prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with docetaxel to placebo in combination with docetaxel in first line metastatic Castrate Resistant Prostate Cancer (mCRPC) |
| Primary sponsor | AB Science |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Philippines;Hong Kong;Slovakia;Morocco;Greece;Spain;Ukraine;Russian Federation;Italy;India;Malaysia;Peru;South Africa;Tunisia;China;Korea, Republic of;Austria;United Kingdom;Czech… |
| Conditions | metastatic Castrate Resistant Prostate Cancer (mCRPC).;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: masitinib 100mg Product Code: AB1010 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Masitinib mesylate CAS Number: 790299-79-5 Current Sponsor code: AB1010 Other descriptive name: MASITINIB Concentration unit: mg… |
| Registration date | Mar 26, 2014 |
| Target size | 550 |
| Secondary IDs | AB12003 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: